UK biotech

Showing 2 posts of 2 posts found.

Circassia raises funds to develop allergy products

April 19, 2011
Research and Development Circassia, UK biotech, biotech

UK biopharma company Circassia has raised £60 million funding for the final stage of development of its anti-allergy products. The …

Trial failures threaten UK biotech

February 18, 2011
Research and Development AML, AS1411, AS1413, Antisoma, Juvista, Renovo, UK biotech, acute myeloid leukaemia, anti-scarring, biotech

A number of late stage failures from British biotech firms have left a looming question mark over the future of …

Latest content